viewRedx Pharma Plc

'It's a particularly exciting time for Redx Pharma' - Capital Network's Riccardo Lowi

Capital Network's Healthcare Analyst Riccardo Lowi gives his view on Redx Pharma Plc (LON:REDX).

''The reason it's a particularly exciting time for the company is because they're moving  their two lead candidates into the clinical stage, it's the first time they're moving a drug candidate into human trials'', Lowi says.

Quick facts: Redx Pharma Plc

Price: 7.75 GBX

Market: AIM
Market Cap: £13.83 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Redx Pharma Plc named herein, including the promotion by the Company of Redx Pharma Plc in any Content on the Site, the Company receives from...



Redx Pharma's chief scientific officer talks grant funding for its fibrosis...

Redx Pharma PLC's (LON:REDX) chief scientific officer Dr Richard Armer speaks to Proactive London's Andrew Scott after announcing they'd won grant funding for their latest project. They're collaborating with the Medicines Discovery Catapult, a government body that helps accelerate the...

on 19/11/19


Holding(s) in Company

3 days, 1 hour ago

Holding(s) in Company

3 days, 2 hours ago

Form 8.5 (EPT/RI)

4 days ago

Form 8.3 - Redx Pharma plc

4 days, 3 hours ago

Form 8.3 - RedX Pharma PLC

4 days, 23 hours ago

Form 8.5 (EPT/RI)

5 days ago

Result of General Meeting

5 days, 23 hours ago

2 min read